The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials

Mesenchymal stromal cells (MSC) have shown potential efficacy in both animal and human trials of acute respiratory distress syndrome (ARDS). Especially during the COVID-19 pandemic, MSC was intensely studied for treating COVID-19-induced ARDS. The purpose of this study is to evaluate the safety and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fengyun, Li, Yiming, Wang, Bingqing, Li, Jianguo, Peng, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857915/
https://www.ncbi.nlm.nih.gov/pubmed/36670442
http://dx.doi.org/10.1186/s13054-022-04287-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857915/
https://www.ncbi.nlm.nih.gov/pubmed/36670442
http://dx.doi.org/10.1186/s13054-022-04287-4

Ejemplares similares